SOFIE Biosciences and OsiriX announce the release of open source transitional image analysis software

CULVER CITY, CA., Friday September 3, 2010 – Sofie Biosciences, a molecular imaging company focused on empowering people with new PET technologies, announces a partnership with the image analysis software group the OsiriX Foundation. Under the agreement, researchers and clinicians will now be able to review preclinical and clinical image data on one comprehensive analysis platform across multiple modalities.

Recently, Sofie Biosciences introduced GENISYS™, the first high-performance, benchtop, cost effective small animal PET system. GENISYS offers a PET imaging solution to complement existing preclinical experiments. By delivering turnkey operation and streamlined workflow, GENISYS uncouples researchers from their dependency on others, allowing for study design and data output on their terms. With the integration of GENISYS and OsiriX, researchers and clinicians now have a valuable translational image analysis tool.

“Sofie Biosciences believes in the mission of OsiriX to lead a paradigm shift in software development with a trend toward sharing and cooperation in the development of imaging software applications,” said Patrick Phelps, President & CEO, Sofie Biosciences. “Sofie worked closely with the OsiriX team to deliver a preclinical tool kit to enhance their existing suite of advanced analysis features. Together, GENISYS and OsiriX address the unmet needs of researchers and clinicians in molecular imaging. This is an important first step in building a community of developers around GENISYS.”